Skip to main content
. 2001 Jan 22;2001(1):CD002060. doi: 10.1002/14651858.CD002060

van Kaam 1998.

Methods Blinding of randomisation: yes 
 Blinding of intervention: can't tell but probably impossible 
 Complete follow‐up: no 
 Blinding of outcome measurement: can't tell
Participants Premature infants, <2000g. 
 Haemolysis excluded. 
 Qualifying SBR determined by age and birthweight from graphs. 
 Fibreoptic n=56, conventional n=68.
Interventions Fibreoptic: BiliBlanket at 35 microwatts/cm2/nm (measured). 
 Convnetional: White light (4 Phillips TLK 40 W/03) at 16 microwatts/cm2/nm (measured).
Outcomes Duration of phototherapy. 
 Use of exchange transfusion. 
 Use of additional phototherapy.
Notes Further data requested
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Low risk A ‐ Adequate